Acoramidis approved for heart condition treatment - PharmaTimes MHRA authorises drug for adults with rare heart muscle damage

#cardiology #Acoramidis #Beyonttra #Bayer #MHRA #cardiomyopathy #varianttransthyretinamyloidosis #wildtypetransthyretinamyloidosis #wildtypeATTRCM #ATTRCM #EMA #transthyretin #TTR #amyloiddeposits #Acoramidishydrochloride #TTRprotein #accesstomedicines
pharmatimes.com/news/acorami...